ConductScience.org, home

Paper · 32905132

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127036991
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial.
Lancet HIV2016https://conductscience.org/library/papers/27036991PubMed
211950737Drug points: Neuropsychiatric complications of nevirapine treatment.BMJ2002https://conductscience.org/library/papers/11950737PubMed
324370963Whoonga and the abuse and diversion of antiretrovirals in Soweto, South Africa.AIDS Behav2014https://conductscience.org/library/papers/24370963PubMed
414731163
Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitors.
HIV Med2004https://conductscience.org/library/papers/14731163PubMed
525350958Dolutegravir: clinical and laboratory safety in integrase inhibitor-naive patients.HIV Clin Trials2014https://conductscience.org/library/papers/25350958PubMed
626555069Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV.PLoS One2015https://conductscience.org/library/papers/26555069PubMed
723702798The HIV antiretroviral drug efavirenz has LSD-like properties.Neuropsychopharmacology2013https://conductscience.org/library/papers/23702798PubMed
819732926Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda.Trans R Soc Trop Med Hyg2010https://conductscience.org/library/papers/19732926PubMed
919187258Valacyclovir neurotoxicity: clinical experience and review of the literature.Eur J Neurol2009https://conductscience.org/library/papers/19187258PubMed
1028442915Efficacy and safety outcomes of sofosbuvir-based treatment regimens for hepatitis C virus-infected patients with or without cirrhosis from phase III clinical trials.Ther Clin Risk Manag2017https://conductscience.org/library/papers/28442915PubMed
1125977241Safety, efficacy and indications of prescription of maraviroc in clinical practice: Factors associated with clinical outcomes.Antiviral Res2015https://conductscience.org/library/papers/25977241PubMed
1226788406Comparison of Antiretroviral Regimens: Adverse Effects and Tolerability Failure that Cause Regimen Switching.Infect Chemother2015https://conductscience.org/library/papers/26788406PubMed
1315307035Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV-infected adults initiating protease inhibitor-containing therapy.Clin Infect Dis2004https://conductscience.org/library/papers/15307035PubMed
1416062101Acute dystonia induced by lamivudine.Clin Neuropharmacol2005https://conductscience.org/library/papers/16062101PubMed
1523955659Whoonga: potential recreational use of HIV antiretroviral medication in South Africa.AIDS Behav2014https://conductscience.org/library/papers/23955659PubMed
161827127Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism.J Clin Endocrinol Metab1991https://conductscience.org/library/papers/1827127PubMed
1726356545Patient Characteristics, Safety, and Tolerability with Telaprevir Treatment for HCV in the Clinic: a Retrospective, Multicenter Study.J Clin Transl Hepatol2014https://conductscience.org/library/papers/26356545PubMed
1821412057
Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection.
AIDS2011https://conductscience.org/library/papers/21412057PubMed
1916287792Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals.Ann Intern Med2005https://conductscience.org/library/papers/16287792PubMed
2011279329Neuropsychiatric toxicity of antiviral treatment in chronic hepatitis C.Dig Dis2000https://conductscience.org/library/papers/11279329PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/32905132/references